Resource-based Centers for Bone, Muscle and Orthopaedic Research
ID: 359147Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/359147
Timeline
    Description

    The National Institutes of Health (NIH) is preparing to announce a funding opportunity for Resource-based Centers focused on Bone, Muscle, and Orthopaedic Research. This initiative aims to establish centers that will provide essential research infrastructure, shared facilities, and resources to support investigators in conducting efficient and effective research projects in these critical areas. The goal is to enhance ongoing basic, translational, and clinical research aligned with the mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). While applications are not currently being solicited, potential applicants are encouraged to develop collaborations and project proposals in anticipation of the funding announcement, which is expected to be published in September 2025. Interested parties can reach out to Dr. Mary Garcia-Cazarin at mary.garcia-cazarin@nih.gov or by phone at 301-451-2937 for further information.

    Point(s) of Contact
    Mary Garcia-Cazarin, Ph.D. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
    (301) 451-2937
    mary.garcia-cazarin@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Resource-based Centers for Rheumatic Diseases Research
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to announce a funding opportunity for Resource-based Centers for Rheumatic Diseases Research, aimed at enhancing research infrastructure for rheumatic diseases. This initiative will support small businesses in providing shared facilities, services, and resources to facilitate collaborative research efforts among investigators in this field. The goal is to accelerate and enrich ongoing basic, translational, and clinical research aligned with the mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). While applications are not currently being solicited, interested parties are encouraged to develop collaborations and project proposals in anticipation of the upcoming Notice of Funding Opportunity (NOFO), with an estimated synopsis posting date of September 3, 2025, and a closing date of November 3, 2025. For further inquiries, potential applicants can contact Dr. Mary Garcia-Cazarin at mary.garcia-cazarin@nih.gov or by phone at 301-451-2937.
    NIAMS Skin Biology and Diseases Resource-based Center (P30 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a forthcoming funding opportunity titled "NIAMS Skin Biology and Diseases Resource-based Center (P30 - Clinical Trial Not Allowed)" aimed at supporting research infrastructure for skin diseases. This initiative seeks to establish resource-based centers that will provide essential facilities, services, and resources to enhance the efficiency and effectiveness of research conducted by groups of investigators in the field of skin diseases. The overall goal is to accelerate and enrich ongoing basic, translational, and clinical research aligned with the mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). While applications are not currently being solicited, interested small businesses are encouraged to prepare collaborative proposals in anticipation of the estimated synopsis posting on September 4, 2025, with a closing date of November 3, 2025, and an expected award date of July 1, 2026. For further inquiries, potential applicants may contact Dr. Mary Garcia-Cazarin at mary.garcia-cazarin@nih.gov or by phone at 301-451-2937.
    Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing an upcoming funding opportunity titled "Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)," aimed at supporting research that leverages resources from ongoing clinical studies. This initiative encourages applications for ancillary studies that utilize well-characterized patient cohorts, infrastructure, data, and biological samples, while aligning with the mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). With an estimated total program funding of $600,000 and the expectation of awarding two grants, potential applicants are advised to begin developing collaborations and project proposals in advance of the official solicitation, which is expected to be published in early 2026. For further inquiries, interested parties may contact Dr. Heiyoung Park at Heiyoung.Park@nih.gov or by phone at 301-594-5032.
    Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for Clinical Observational (CO) Studies focused on musculoskeletal, rheumatic, and skin diseases, under the grant title PAR-24-036. This grant, which does not allow clinical trials, aims to support observational studies that collect critical data to inform future clinical research, particularly regarding disease symptoms, progression, and participant eligibility, while also exploring telehealth and digital outcomes. The initiative is designed to enhance the rigor of future clinical trials through comprehensive data collection from diverse populations, ultimately improving patient outcomes in affected communities. The grant provides up to $475,000 over four years, with applications opening on February 4, 2024, and funding decisions expected by late 2024. Interested applicants can find more information and guidelines at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Core Centers for Clinical Research (CCCR) (P30 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Core Centers for Clinical Research (CCCR)" aimed at advancing methodological sciences in clinical research related to musculoskeletal, rheumatic, and skin diseases. This initiative seeks to establish centers that will focus on the prevention, diagnosis, and treatment of these conditions, emphasizing the development of novel methods and metrics while ensuring community representation throughout the research process. Eligible applicants include small businesses, with no cost-sharing or matching requirements, and the estimated project start date is set for July 1, 2027. Interested parties can reach out to Dr. Melissa C. Green Parker at melissa.greenparker@nih.gov or by phone at 240-755-3031 for further information, with the application period expected to close on September 25, 2026.
    Renewal of NIA Research Centers Collaborative Network (RCCN)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the renewal of the Research Centers Collaborative Network (RCCN), aimed at enhancing collaborations across its seven research centers focused on aging research. This initiative seeks to leverage NIH's significant investments by fostering interdisciplinary efforts and sustaining high-value activities, while also encouraging new initiatives such as pilot funding programs and enhanced mentoring infrastructure. Interested applicants, particularly those with expertise in aging research, are advised to prepare for this opportunity, with the estimated synopsis posting date on March 1, 2026, and a closing date for applications anticipated by May 25, 2026. For further inquiries, potential applicants can contact Amelia Karraker at amelia.karraker@nih.gov or by phone at 301-496-3131.
    Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering funding opportunities through the "Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases" program, specifically under the R61 Clinical Trial mechanism. This initiative aims to support short-term exploratory clinical trials that investigate treatments for rheumatic, musculoskeletal, and skin conditions, with a focus on diverse therapeutic approaches. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and state and local governments, with a maximum budget of $600,000 for a three-year project, not exceeding $300,000 in any single year. Applications must be submitted electronically via Grants.gov, with key deadlines starting from February 4, 2024, and inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov. For more details, visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-035.html.
    Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases under the R01 Research Project Grant program. This initiative aims to support observational studies that gather critical data to inform future clinical research, focusing on understanding disease symptoms, progression, participant recruitment strategies, and potential biomarkers. The funding opportunity is significant for enhancing research outcomes in health fields related to these diseases, with applicants eligible to request up to $475,000 over four years. Key deadlines include an application submission start date of February 4, 2025, and a final expiration date of November 3, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    HEAL NOFO for the HEAL INTERACT Data Center
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a Notice of Funding Opportunity (NOFO) for the HEAL INTERACT Data Center, aimed at addressing musculoskeletal and peripheral pain through integrated research initiatives. This cooperative agreement seeks to fill knowledge gaps and identify novel research directions in the field, encouraging collaborative investigations among experts in pain mechanisms. While applications are not currently being solicited, potential applicants are urged to prepare meaningful collaborations and responsive projects, with an estimated synopsis post date of September 25, 2025, and a projected award date of August 3, 2026. For further inquiries, interested parties can contact Dr. Rebecca Lenzi at rebecca.lenzi@nih.gov or by phone at 301-408-7447.
    Informatics, Coordination and Service Center for the Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the Informatics, Coordination and Service Center (ICSC) within the Mutant Mouse Resource and Research Centers (MMRRC) consortium, aimed at enhancing biomedical research through improved informatics services. The initiative seeks to support projects that develop and assist resources related to animal and biological materials, focusing on the integration of new approach methodologies (NAMs) alongside traditional animal-based research. This funding opportunity, utilizing the U42 activity code, is expected to provide a total of $878,000, with one award anticipated, and applications will be accepted starting in Summer 2025, following the NOFO publication in Spring 2025. For further inquiries, interested applicants can contact Dr. Oleg Mirochnitchenko at oleg.mirochnitchenko@nih.gov or by phone at 301-425-0479.